← catalyst

BIIB

2 catalysts · 1 upcoming · 0 awaiting · 1 resolved

Upcoming

[PDUFA]·Apr 30, 2026
T-1d

AXS-05 (dextromethorphan HBr and bupropion HCl) - (ACCORD-2) (AXSM) PDUFA — Agitation in patients with Alzheimer’s disease (AD)

▸ analysis · bull/bear · base rate — pro
AXSMOTSKYLLYBIIB

Resolved

[PDUFA]·Jul 6, 2023
→ FAVORABLE

Lecanemab (Leqembi) — Traditional approval for Alzheimer's disease

▸ analysis · bull/bear · base rate — pro
BIIBLLYPRTAACIU